Stock Price Forecast

March 28, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Precision Biosciences Inc chart...

About the Company

precision biosciences, inc. is a biotechnology company located in durham, north carolina, united states.

$102M

Total Revenue

218

Employees

$56M

Market Capitalization

-13.27

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $DTIL News

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update

2d ago, source:

Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform ...

Buy Rating Affirmed for Precision BioSciences on Promising Gene Editing Prospects and Strong Financials

23h ago, source:

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Precision BioSciences (DTIL – Research Report). The ...

Precision Biosciences files patent for engineered meganuclease for treating hepatitis B virus infections

3d ago, source: Pharmaceutical Technology

Discover Precision Biosciences' groundbreaking patent for engineered meganucleases targeting Hepatitis B virus, offering improved characteristics for treating infections and hepatocellular carcinoma.

Buy Rating Affirmed for Precision BioSciences as Milestones in Gene Editing Technology Loom

1d ago, source:

Analyst Soumit Roy of JonesTrading maintained a Buy rating on Precision BioSciences (DTIL – Research Report), retaining the price target ...

Precision BioSciences: Q4 Earnings Snapshot

2d ago, source:

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — Precision BioSciences Inc. (DTIL) on Wednesday reported a loss of $16.3 million in its fourth quarter. The Durham, North Carolina-based company said it had a ...

Precision Biosciences Flat On New Product Development

9d ago, source:

AstraZenca Buys Fusion for $2 <li /> Kroger Set to Sell Pharmacy Arm <li /> Howard Hughes Links up with Discovery Land <li /> ...

Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024

8d ago, source: Business Wire

Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene e ...

Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy

10d ago, source: Stockhouse

Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS&circledR; platform to develop in vivo gene editing therapies for sophisticated gene ...

WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF

14h ago, source:

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on ...

Precision BioSciences Q4 Earnings Preview

on MSN ago, source:

The consensus EPS Estimate is -$2.03 (-680.8% Y/Y) and the consensus Revenue Estimate is $14.46M (+36.5% Y/Y).Over the last 1 year, DTIL has beaten EPS estimates 50% of the time and has beaten revenue ...

Earnings Preview: Precision BioSciences

2d ago, source:

Analysts estimate that Precision BioSciences will report an earnings per share (EPS) of $-2.05. Precision BioSciences bulls will hope to hear the company announce they've not only beaten that estimate ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...